tirzepatide systematic review Risk of suicidal thoughts and dizziness associated with tirzepatide: A and meta-analysis Tirzepatide on ingestive behavior in
Description
In the SURMOUNT-1 obesity trial, participants lost an average of 15% to 21% of their body weight over 72 weeks
Two studies reported hair loss as an adverse event
Unopened tirzepatide needs to chill between 36F and 46F (2C8C)
If that happens, press lightly onto the injection site with a cotton ball or some gauze
The tradeoff is that low doses become harder to measure precisely
